438554-17-7 Usage
Structure
Imidazole derivative It is a chemical compound derived from imidazole, which is a five-membered heterocyclic ring containing two nitrogen atoms.
Substitution
3-chloro-4-fluorophenyl group The imidazole moiety is substituted with a 3-chloro-4-fluorophenyl group, which consists of a phenyl ring with a chlorine atom at the 3rd position and a fluorine atom at the 4th position.
Potential applications
Pharmacology and medicinal chemistry The compound has potential applications in the field of pharmacology and medicinal chemistry due to its diverse biological activities.
Biological activities
Antimicrobial, antifungal, and anti-inflammatory properties Imidazole derivatives are known for their various biological activities, including fighting against infections, fungi, and reducing inflammation.
Interest for further research
Pharmaceutical industry Due to its unique structure and potential biological activities, 2-(3-chloro-4-fluoro-phenyl)-1H-imidazole may be of interest for additional research and development within the pharmaceutical industry.
Check Digit Verification of cas no
The CAS Registry Mumber 438554-17-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,3,8,5,5 and 4 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 438554-17:
(8*4)+(7*3)+(6*8)+(5*5)+(4*5)+(3*4)+(2*1)+(1*7)=167
167 % 10 = 7
So 438554-17-7 is a valid CAS Registry Number.
438554-17-7Relevant articles and documents
Heteroaryl substituted fused bicyclic heteroaryl compound as GABAA receptor ligands
-
, (2008/06/13)
This invention relates to heteroaryl substituted fused bicyclic heteroaryl compounds, such as heteroaryl substituted imidazopyridines, imidazopyrazines, imidazopyridizines, imidazopyrimidines, and imidazothiazoles, which may be described by Formula I or F
Benzimidazole and pyridylimidazole derivatives
-
, (2008/06/13)
This invention relates to benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds, all of which may be described by of Formula I The invention is particularly related to such compounds that bind with high selectivity and high affinity to the benzodiazepine site of GABAA receptors. This invention also relates to pharmaceutical compositions comprising such compounds and to the use of such compounds in treatment of certain central nervous system (CNS) diseases. Novel processes for preparing compounds of Formula I are disclosed. This invention also relates to the use of benzimidazoles, pyridylimidazoles and related bicyclic heteroaryl compounds of Formula I in combination with one or more other CNS agents to potentiate the effects of the other CNS agents. Additionally this invention relates to the use such compounds as probes for the localization of GABAA receptors in tissue sections.
